Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8+ T Cells in Mice With Colitis

Gastroenterology

Volumn 149, Issue 4, 2015, Pages 993-1005.e2

  Punit, Shivesh ^a   Dubé, Philip E ^a   Liu, Cambrian Y ^a   Girish, Nandini ^a   Washington, M Kay ^b   Polk, D Brent ^a,c  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Crohn's Disease; Cytokine; Mouse Model; Ulcerative Colitis

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR 2; DNA BINDING PROTEIN; IL10 PROTEIN, MOUSE; INTERLEUKIN 10; RAG2 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CD8+ T LYMPHOCYTE; CELL EXPANSION; COLITIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTOLOGY; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INCIDENCE; INFLAMMATORY BOWEL DISEASE; MALE; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CELLULAR IMMUNITY; COLON; DEFICIENCY; DISEASE MODEL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; TIME FACTOR; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; COLITIS; COLON; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; IMMUNITY, CELLULAR; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84942306162     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.06.004     Document Type: Article

References (53)

1. H. Loetscher, E.J. Schlaeger, H.W. Lahm, and et al. Purification and partial amino acid sequence analysis of two distinct tumor necrosis factor receptors from HL60 cells J Biol Chem 265 1990 20131 20138
2. S.H. Murch, V.A. Lamkin, M.O. Savage, and et al. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease Gut 32 1991 913 917
3. P. Rutgeerts, W.J. Sandborn, B.G. Feagan, and et al. Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2005 2462 2476
4. S.R. Targan, S.B. Hanauer, S.J. van Deventer, and et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group N Engl J Med 337 1997 1029 1035
5. P. Dube, S. Punit, and D.B. Polk Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol 308 2015 G161 G170
6. H. Sashio, K. Tamura, R. Ito, and et al. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively Immunogenetics 53 2002 1020 1027
7. K.A. Waschke, A.C. Villani, S. Vermeire, and et al. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes Am J Gastroenterol 100 2005 1126 1133
8. E. Mizoguchi, A. Mizoguchi, H. Takedatsu, and et al. Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice Gastroenterology 122 2002 134 144
9. G.C. Kaiser, and D.B. Polk Tumor necrosis factor alpha regulates proliferation in a mouse intestinal cell line Gastroenterology 112 1997 1231 1240
10. J. Corredor, F. Yan, C.C. Shen, and et al. Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms Am J Physiol Cell Physiol 284 2003 C953 C961
11. L. Su, S.C. Nalle, L. Shen, and et al. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis Gastroenterology 145 2013 407 415
12. E. Mizoguchi, Y. Hachiya, M. Kawada, and et al. TNF receptor type I-dependent activation of innate responses to reduce intestinal damage-associated mortality Gastroenterology 134 2008 470 480
13. D.R. Ebach, R. Newberry, and W.F. Stenson Differential role of tumor necrosis factor receptors in TNBS colitis Inflamm Bowel Dis 11 2005 533 540
14. J. Dayer Schneider, I. Seibold, N. Saxer-Sekulic, and et al. Lack of TNFR2 expression by CD4(+) T cells exacerbates experimental colitis Eur J Immunol 39 2009 1743 1753
15. M. Nakai, K. Sudo, Y. Yamada, and et al. The role of the tumor necrosis factor receptor in 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice Dig Dis Sci 50 2005 1669 1676
16. H.S. Teh, A. Seebaran, and S.J. Teh TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death J Immunol 165 2000 4814 4821
17. J.C. Lee, P.A. Lyons, E.F. McKinney, and et al. Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis J Clin Invest 121 2011 4170 4179
18. J.A. Goettel, H.M. Scott Algood, D. Olivares-Villagomez, and et al. KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-gamma production Gastroenterology 140 2011 265 274
19. D. Grcevic, S.K. Lee, A. Marusic, and et al. Depletion of CD4 and CD8 T lymphocytes in mice in vivo enhances 1,25-dihydroxyvitamin D3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis J Immunol 165 2000 4231 4238
20. M. Tajima, D. Wakita, D. Noguchi, and et al. IL-6-dependent spontaneous proliferation is required for the induction of colitogenic IL-17-producing CD8+ T cells J Exp Med 205 2008 1019 1027
21. R.J. Kennedy, M. Hoper, K. Deodhar, and et al. Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease Br J Surg 87 2000 1346 1351
22. A. Franke, T. Balschun, T.H. Karlsen, and et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility Nat Genet 40 2008 1319 1323
23. E.O. Glocker, D. Kotlarz, K. Boztug, and et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor N Engl J Med 361 2009 2033 2045
24. D. Rennick, N. Davidson, and D. Berg Interleukin-10 gene knock-out mice: a model of chronic inflammation Clin Immunol Immunopathol 76 1995 S174 S178
25. P.E. Dube, F. Yan, S. Punit, and et al. Epidermal growth factor receptor inhibits colitis-associated cancer in mice J Clin Invest 122 2012 2780 2792
26. C. Neufert, C. Becker, and M.F. Neurath An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression Nat Protoc 2 2007 1998 2004
27. N.J. Davidson, M.M. Fort, W. Muller, and et al. Chronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response Int Rev Immunol 19 2000 91 121
28. S. Muller, J. Lory, N. Corazza, and et al. Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease Am J Pathol 152 1998 261 268
29. M.A. Brehm, K.A. Daniels, and R.M. Welsh Rapid production of TNF-alpha following TCR engagement of naive CD8 T cells J Immunol 175 2005 5043 5049
30. E.Y. Kim, S.J. Teh, J. Yang, and et al. TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth J Immunol 183 2009 6051 6057
31. Y.C. Twu, M.R. Gold, and H.S. Teh TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells Eur J Immunol 41 2011 335 344
32. T.S. Heng, and M.W. Painter Immunological Genome Project Consortium. The Immunological Genome Project: networks of gene expression in immune cells Nat Immunol 9 2008 1091 1094
33. A. Subramanian, P. Tamayo, V.K. Mootha, and et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci U S A 102 2005 15545 15550
34. M. Wang, D. Windgassen, and E.T. Papoutsakis Comparative analysis of transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel immune response players in T-cell activation BMC Genomics 9 2008 225
35. D. Croft, G. O'Kelly, G. Wu, and et al. Reactome: a database of reactions, pathways and biological processes Nucleic Acids Res 39 2011 D691 D697
36. T. ten Hove, C. van Montfrans, M.P. Peppelenbosch, and et al. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease Gut 50 2002 206 211
37. P. Eder, L. Lykowska-Szuber, I. Krela-Kazmierczak, and et al. The influence of infliximab and adalimumab on the expression of apoptosis-related proteins in lamina propria mononuclear cells and enterocytes in Crohn's disease - an immunohistochemical study J Crohns Colitis 7 2013 706 716
38. I. Ferkolj, A. Ihan, S. Markovic, and et al. Infliximab reduces the number of activated mucosal lymphocytes in patients with Crohn's disease J Gastrointestin Liver Dis 15 2006 231 235
39. L. Ban, J. Zhang, L. Wang, and et al. Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism Proc Natl Acad Sci U S A 105 2008 13644 13649
40. D. Faustman, and M. Davis TNF receptor 2 pathway: drug target for autoimmune diseases Nat Rev Drug Discov 9 2010 482 493
41. S. Kodama, W. Kuhtreiber, S. Fujimura, and et al. Islet regeneration during the reversal of autoimmune diabetes in NOD mice Science 302 2003 1223 1227
42. H.A. Arnett, J. Mason, M. Marino, and et al. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination Nat Neurosci 4 2001 1116 1122
43. R.S. Al-Lamki, W. Lu, J. Wang, and et al. TNF, acting through inducibly expressed TNFR2, drives activation and cell cycle entry of c-Kit+ cardiac stem cells in ischemic heart disease Stem Cells 31 2013 1881 1892
44. X. Chen, J.J. Subleski, H. Kopf, and et al. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells J Immunol 180 2008 6467 6471
45. P.E. Dube, F. Yan, S. Punit, and et al. Epidermal growth factor receptor inhibits colitis-associated cancer in mice J Clin Invest 122 2012 2780 2792
46. W.S. Garrett, G.M. Lord, S. Punit, and et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system Cell 131 2007 33 45
47. G.P. Boivin, K. Washington, K. Yang, and et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations Gastroenterology 124 2003 762 777
48. D. Kim, G. Pertea, C. Trapnell, and et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions Genome Biol 14 2013 R36
49. D. Croft, G. O'Kelly, G. Wu, and et al. Reactome: a database of reactions, pathways and biological processes Nucleic Acids Res 39 2011 D691 D697
50. M. Milacic, R. Haw, K. Rothfels, and et al. Annotating cancer variants and anti-cancer therapeutics in reactome Cancers (Basel) 4 2012 1180 1211
51. L. Jostins, S. Ripke, R.K. Weersma, and et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease Nature 491 2012 119 124
52. T.S. Heng, M.W. Painter Immunological Genome Project Consortium The Immunological Genome Project: networks of gene expression in immune cells Nat Immunol 9 2008 1091 1094
53. M.S. Cline, M. Smoot, E. Cerami, and et al. Integration of biological networks and gene expression data using Cytoscape Nat Protoc 2 2007 2366 2382